Insmed Incorporated
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-31.59-55.82582.4947.01
Price/Sales ratio
29.1716.7310.097.08
Earnings per Share (EPS)
$-4.03$-2.28$0.21$2.71

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.40-8.98-4.64-10.77-3.10-7.93-11.04-7.02-5.10-5.80-4.64-4.64
Price/Sales ratio
57.87N/AN/AN/A102.5014.7919.7616.2010.0114.259.1214.79
Price/Book Value ratio
3.573.405.295.744.847.7111.777.4427.95-13.1125.454.84
Price/Cash Flow ratio
-10.33-10.54-5.57-13.00-3.90-8.05-14.81-8.40-6.13-8.11-5.59-5.59
Price/Free Cash Flow ratio
-9.53-10.19-5.42-12.76-3.69-6.89-14.36-8.24-5.99-7.91-5.45-5.45
Price/Earnings Growth ratio
-0.56-0.91-0.11-7.67-0.060.27N/A-0.24-6.60-0.155.45-0.06
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-191.60%N/AN/AN/A75.36%82.25%75.74%76.57%77.53%78.51%77.53%75.36%
Operating Profit Margin
-759.69%N/AN/AN/A-3124.94%-172.38%-161.32%-195.13%-194.86%-232.50%-191.12%-3124.94%
Pretax Profit Margin
-778.96%N/AN/AN/A-3295.12%-185.80%-178.02%-231.56%-195.69%-244.75%-195.69%-3295.12%
Net Profit Margin
-688.33%N/AN/AN/A-3297.17%-186.37%-178.87%-230.63%-196.25%-245.59%-196.25%-3297.17%
Effective Tax Rate
11.63%1.64%-0.05%0.14%-0.06%-0.30%-0.47%0.40%-0.28%-0.34%-0.28%-0.30%
Return on Assets
-34.28%-33.14%-74.07%-41.69%-53.63%-34.26%-36.93%-34.95%-29.07%-56.36%-29.07%-53.63%
Return On Equity
-42.50%-37.91%-114.10%-53.35%-155.70%-97.19%-106.59%-105.89%-547.50%225.82%-867.18%-97.19%
Return on Capital Employed
-41.35%-35.14%-82.58%-45.26%-58.56%-35.80%-39.15%-33.18%-32.60%-64.26%-31.98%-58.56%
Liquidity Ratios
Current Ratio
8.3912.946.018.726.506.515.24N/AN/AN/A6.696.50
Quick Ratio
8.3912.946.018.726.426.184.825.696.323.746.196.19
Cash ratio
8.1112.705.808.536.205.714.485.305.642.135.645.71
Days of Sales Outstanding
N/AN/AN/AN/A204.6751.4336.7647.1644.2049.2544.2051.43
Days of Inventory outstanding
N/AN/AN/AN/A1.05K426.82453.97553.95462.96463.38462.96426.82
Operating Cycle
N/AN/AN/AN/A1.26K478.26490.74601.11507.16512.64473.86478.26
Days of Payables Outstanding
100.661.37K1.56K1.84K2.67K198.75392.28295.82334.11363.99334.11334.11
Cash Conversion Cycle
-100.66N/AN/AN/A-1.40K279.5198.45305.29173.05148.64-175.75-1.40K
Debt Ratios
Debt Ratio
0.100.070.230.120.520.530.500.490.670.860.940.52
Debt Equity Ratio
0.130.080.350.151.511.511.461.4912.79-3.4817.831.51
Long-term Debt to Capitalization
0.110.060.260.130.600.590.580.590.921.400.930.60
Total Debt to Capitalization
0.110.070.260.130.600.600.590.590.921.400.930.60
Interest Coverage Ratio
-36.17-40.66-49.57-31.88-12.06-8.94-9.41N/AN/AN/A-22.53-8.94
Cash Flow to Debt Ratio
-2.59-4.00-2.67-2.87-0.81-0.63-0.54-0.59-0.35-0.46-0.33-0.81
Company Equity Multiplier
1.231.141.541.272.902.832.883.0218.83-4.0018.832.90
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-5.60N/AN/AN/A-26.23-1.83-1.33-1.92-1.63-1.75-1.63-26.23
Free Cash Flow / Operating Cash Flow Ratio
1.081.031.021.011.051.161.031.021.021.021.021.16
Cash Flow Coverage Ratio
-2.59-4.00-2.67-2.87-0.81-0.63-0.54-0.59-0.35-0.46-0.33-0.81
Short Term Coverage Ratio
N/A-32.34N/AN/AN/A-20.44-17.46-35.84N/AN/A-49.27-20.44
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A